Evidence map›Paper›PMID 32818079›Full record

ArticleTranslational vision science & technology2020

Deep Neural Network for Scleral Spur Detection in Anterior Segment OCT Images: The Chinese American Eye Study.

Benjamin Y Xu, Michael Chiang, Anmol A Pardeshi, Sasan Moghimi, Rohit Varma

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Artificial Intelligence for Optical Coherence Tomography in Glaucoma.Translational vision science & technology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Performance of the Deep Neural NetworkDiagnostics (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Benjamin Y XuRoski Eye Institute, Department of Ophthalmology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
Michael ChiangSol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA.
Anmol A PardeshiRoski Eye Institute, Department of Ophthalmology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
Sasan MoghimiHamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California, San Diego, La Jolla, CA, USA.
Rohit VarmaSouthern California Eye Institute, CHA Hollywood Presbyterian Medical Center, Los Angeles, CA, USA.
University of Southern California · USSouthern California Eye Institute · USUniversity of California, San Diego · US

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Chinese American Eye StudyU10EY017337 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI VARMA, ROHIT · 2009 to 2013
$10.2M
Ophthalmic Therapeutics Engineering CoreP30EY029220 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Qifa Zhou · 2018 to 2026
$6.5M
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure DiseaseK23EY029763 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI XU, BENJAMIN Y. · 2019 to 2023
$1.1M
NCATS NIH HHS UL1 TR001855NEI NIH HHS K23 EY029763NEI NIH HHS P30 EY029220NEI NIH HHS U10 EY017337
6 · The paper itself

Abstract

Purpose: To develop a deep neural network that detects the scleral spur in anterior segment optical coherence tomography (AS-OCT) images. Methods: Participants in the Chinese American Eye Study, a population-based study in Los Angeles, California, underwent complete ocular examinations, including AS-OCT imaging with the Tomey CASIA SS-1000. One human expert grader provided reference labels of scleral spur locations in all images. A convolutional neural network (CNN)-based on the ResNet-18 architecture was developed to detect the scleral spur in each image. Performance of the CNN model was assessed by calculating prediction errors, defined as the difference between the Cartesian coordinates of reference and CNN-predicted scleral spur locations. Prediction errors were compared with intragrader variability in detecting scleral spur locations by the reference grader. Results: The CNN was developed using a training dataset of 17,704 images and tested using an independent dataset of 921 images. The mean absolute prediction errors of the CNN model were 49.27 ± 42.07 µm for X-coordinates and 47.73 ± 39.70 µm for Y-coordinates. The mean absolute intragrader variability was 52.31 ± 47.75 µm for X-coordinates and 45.88 ± 45.06 µm for Y-coordinates. Distributions of prediction errors for the CNN and intragrader variability for the reference grader were similar for X-coordinates ( Conclusions: A deep neural network can detect the scleral spur on AS-OCT images with performance similar to that of a human expert grader. Translational Relevance: Deep learning methods that automate scleral spur detection can facilitate qualitative and quantitative assessments of AS-OCT images.

Indexed as

Glaucoma, Angle-ClosureNeural Networks, ComputerScleraAsianHumansLos Angelesangle closureanterior segment OCTartificial intelligencedeep learning

Identifiers

PMID32818079
PMCPMC7395674
OpenAlexW3013197430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.